Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
Taiwan shares end down in reduced turnover
08/24/2026 05:34 PM - Business
Business group raises concerns over labor shortage in white paper
08/24/2026 05:26 PM - Society
Heavy rain triggers flooding across southern, eastern Taiwan
08/24/2026 04:54 PM - Science & Tech
Taiwan can become global precision health innovation hub: Scholar
08/24/2026 04:49 PM - Business
U.S. dollar closes higher on Taipei forex market
08/24/2026 04:16 PM